# FZATA, INC.: A novel oral immunotherapy for chronic visceral pain of irritable bowel syndrome

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | FZATA, INC. |
| Location | HALETHORPE, MD |
| Project | A novel oral immunotherapy for chronic visceral pain of irritable bowel syndrome |
| Project number | 4UH3NS135350-02 |
| Mechanism | UH3 |
| Institute | National Institute of Neurological Disorders and Stroke |
| Award | $2,058,422 |
| Awarded | 2026-09-19 |
| Project period | 2024-09-01 to 2029-08-31 |
| UEI | SLGDVHJS1Y85 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11190585). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.